Novartis cuts jobs as New Vernon Equities upgrades East Hanover campus

The commercial landscape in East Hanover is shifting rapidly as two major developments unfold simultaneously on Arena Way. On one hand, pharmaceutical giant Novartis announced plans to eliminate an additional 76 positions at its U.S. headquarters this month. This reduction marks the latest step in a global restructuring plan that continues to impact the local workforce.

On the other side of campus activity, New Vernon Equities is nearing completion on extensive exterior upgrades for two vacant office towers adjacent to the Novartis site. The locally based investment group has committed more than $20 million over the past year to reposition these buildings into a modern workplace destination. This aggressive speculative investment aims to transform 350,000 square feet of space at 20 and 40 Arena Way.

Separation from Novartis Campus

Since acquiring the buildings from Novartis, New Vernon Equities has undertaken a physical and operational separation of these assets from the drug company's downsized campus. The improvements include construction of new roadways to establish independent site access for tenants who do not work at Novartis. Developers also created standalone utility infrastructure to replace a previously shared campus-wide central plant facility.

This separation allows the properties to function as distinct entities rather than relying on the pharmaceutical giant's internal systems. It signals a clear transition of the area from a single-company hub to a mixed-use business park capable of supporting multiple tenants independently.

Modernization and Sustainability Goals

The developer is completing site enhancements that include elevated outdoor meeting areas, hospitality-driven gathering spaces, and upgraded landscaping designed to activate the campus environment. The buildings now feature new HVAC systems and a modern building management system to support high-tech operations. These upgrades are part of a broader effort to meet rigorous environmental standards.

The property holds a LEED Gold certification and has been converted to all-electric operations, achieving the RE100 certification for renewable energy use. With exterior and systems upgrades substantially complete, New Vernon Equities is finalizing designs for interior renovations and next-generation common area amenities. Plans are set to be submitted in the second quarter of 2026 with work expected to finish this summer.

Broader Arena Campus Redevelopment

The current project is part of a larger redevelopment plan where Arena spans over 40 acres and will ultimately comprise six buildings totaling 600,000 square feet. The final complex is designed to house office space, research and development facilities for technology firms, and light manufacturing areas. New Vernon Equities previously acquired four surrounding properties to facilitate this expansion.

Among the existing assets in the portfolio is 30 Farinella Drive, a 75,000-square-foot building fully leased to GenScript for GMP pharma manufacturing operations. The developer also owns 31 Farinella Drive, which is a tech and flex building currently available for lease with specific square footage details provided in the source text as 48,8350 square feet.

Construction on another key component of the campus is scheduled to begin soon at 80 Arena Way. This site will become a 120,000-square-foot tech and flex building starting construction in Summer 2026. The JLL leasing team has been retained as the exclusive marketing and leasing agent for these developments.

Market Reaction and Leasing Strategy

The JLL leasing team includes Executive Managing Directors Tim Greiner and Blake Goodman along with Executive Vice President Colleen Maguire who are handling tenant placement efforts. Greiner noted that it is rare in today's office market to see a developer invest this aggressively on a speculative basis without guaranteed tenants first.

He stated that New Vernon Equities is delivering infrastructure, sustainability, and amenity upgrades that position Arena to compete at the highest level for life sciences, pharmaceutical, and innovation-driven users. This strategy suggests confidence in the continued demand for specialized space despite broader economic uncertainties affecting large employers like Novartis.

The contrast between job cuts at a major anchor tenant and heavy investment by private developers highlights the evolving nature of Morris County's industrial corridor. While one company downsizes its footprint, new capital is flowing into adjacent properties to attract different types of businesses focused on manufacturing and technology innovation.